CDK9 and breast cancer: These roles are reinforced by the induction of apoptosis and inhibition of cell growth in both hormone therapy-sensitive and -resistant ER+ breast cancer cell lines (e.g., MCF-7) as a consequence of CDK9 inhibition by biological or pharmacological means (154, 155, 206).